Literature DB >> 11888355

Nosocomial pneumonia in pediatric patients: practical problems and rational solutions.

Heather J Zar1, Mark F Cotton.   

Abstract

Nosocomial pneumonia is a common hospital-acquired infection in children, and is often fatal. Risk factors for nosocomial pneumonia include admission to an intensive care unit, intubation, burns, surgery, and underlying chronic illness. Viruses, predominantly respiratory syncytial virus (RSV), are the most common cause of pediatric nosocomial respiratory tract infections. Gram-negative bacteria (Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa) are the predominant bacterial pathogens, and are associated with a high mortality rate. Staphylococcus aureus and Staphylococcus epidermidis are the most common Gram-positive bacteria causing nosocomial pneumonia; infections with these organisms have a better outcome than those with Gram-negative organisms. An increasing problem is the emergence of multiresistant Gram-positive and Gram-negative nosocomial pathogens. Distinguishing nosocomial pneumonia from other pulmonary processes may be difficult; diagnosis is based on clinical signs, radiological findings, and microbiological results. Recommended empiric therapy should consider factors such as the time of onset of illness, severity of disease, and specific risk factors for nosocomial pneumonia, including use of mechanical ventilation, underlying disease, or recent use of antibacterials. The resident local hospital flora should be considered when selecting therapy for nosocomial pneumonia. Early initiation of appropriate empiric therapy reduces morbidity and mortality. For empiric treatment of bacterial nosocomial pneumonia, an intravenous antibacterial regimen that includes coverage of Gram-negative bacilli and Gram-positive organisms should be used. A carbapenem or ureidopenicillin derivative (piperacillin) plus a beta-lactamase inhibitor should be used where extended spectrum beta-lactamase-producing Enterobacteriaceae are endemic. Therapy should be modified when a specific pathogen and its antimicrobial susceptibility are identified. Effective prevention of nosocomial pneumonia requires infection control measures that affect the environment, personnel, and patients. Of these, hand hygiene, appropriate infection control policies, and judicious use of antibacterials are essential.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888355     DOI: 10.2165/00128072-200204020-00001

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  102 in total

1.  Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial.

Authors:  N M Apte; D R Karnad; T P Medhekar; G H Tilve; S Morye; G G Bhave
Journal:  Crit Care Med       Date:  1992-05       Impact factor: 7.598

2.  Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia : potential economic implications.

Authors:  A F Shorr; P G O'Malley
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

3.  Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia.

Authors:  C M Luna; A Videla; J Mattera; C Vay; A Famiglietti; P Vujacich; M S Niederman
Journal:  Chest       Date:  1999-10       Impact factor: 9.410

Review 4.  Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.

Authors:  C M Perry; A Markham
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

5.  Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System.

Authors:  M J Richards; J R Edwards; D H Culver; R P Gaynes
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

6.  Mechanical ventilation with or without 7-day circuit changes. A randomized controlled trial.

Authors:  M H Kollef; S D Shapiro; V J Fraser; P Silver; D M Murphy; E Trovillion; M L Hearns; R D Richards; L Cracchilo; L Hossin
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

7.  Methicillin-resistant Staphylococcus aureus in Europe.

Authors:  A Voss; D Milatovic; C Wallrauch-Schwarz; V T Rosdahl; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-01       Impact factor: 3.267

8.  Nosocomial infection in pediatric surgical patients: a study of 608 infants and children.

Authors:  N Bhattacharyya; A M Kosloske; C Macarthur
Journal:  J Pediatr Surg       Date:  1993-03       Impact factor: 2.545

9.  Weekly ventilator circuit changes. A strategy to reduce costs without affecting pneumonia rates.

Authors:  D Hess; E Burns; D Romagnoli; R M Kacmarek
Journal:  Anesthesiology       Date:  1995-04       Impact factor: 7.892

10.  Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia.

Authors:  J Vallés; A Artigas; J Rello; N Bonsoms; D Fontanals; L Blanch; R Fernández; F Baigorri; J Mestre
Journal:  Ann Intern Med       Date:  1995-02-01       Impact factor: 25.391

View more
  8 in total

Review 1.  Emerging infections in burns.

Authors:  Ludwik K Branski; Ahmed Al-Mousawi; Haidy Rivero; Marc G Jeschke; Arthur P Sanford; David N Herndon
Journal:  Surg Infect (Larchmt)       Date:  2009-10       Impact factor: 2.150

2.  Epidemiologic surveillance of nosocomial infections in a Pediatric Intensive Care Unit of a developing country.

Authors:  María R Becerra; José A Tantaleán; Víctor J Suárez; Margarita C Alvarado; Jorge L Candela; Flor C Urcia
Journal:  BMC Pediatr       Date:  2010-09-10       Impact factor: 2.125

3.  Audit of therapeutic interventions in inpatient children using two scores: are they evidence-based in developing countries?

Authors:  Nilton Y Carreazo; Carlos A Bada; Juan P Chalco; Luis Huicho
Journal:  BMC Health Serv Res       Date:  2004-12-29       Impact factor: 2.655

Review 4.  Nosocomial pneumonia : rationalizing the approach to empirical therapy.

Authors:  Gunnar I Andriesse; Jan Verhoef
Journal:  Treat Respir Med       Date:  2006

5.  A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients.

Authors:  Miroslava Bosheva; Rusudan Gujabidze; Éva Károly; Agnes Nemeth; Mikael Saulay; Jennifer I Smart; Kamal A Hamed
Journal:  Pediatr Infect Dis J       Date:  2021-06-01       Impact factor: 2.129

6.  A retrospective observational study of biomarker levels and severity assessment in pediatric community-acquired pneumonia.

Authors:  Anam Bashir; Raheel Khan; Stephanie Thompson; Manuel Caceres
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

7.  Tsr Chemoreceptor Interacts With IL-8 Provoking E. coli Transmigration Across Human Lung Epithelial Cells.

Authors:  Bing Han; Manshu Li; Yonghao Xu; Diana Islam; Julie Khang; Lorenzo Del Sorbo; Warren Lee; Katalin Szaszi; Nanshan Zhong; Arthur S Slutsky; Yimin Li; Haibo Zhang
Journal:  Sci Rep       Date:  2016-08-10       Impact factor: 4.379

8.  Epidemiology, microbiology, and treatment patterns of pediatric patients hospitalized with pneumonia at two hospitals in China: a patient chart review study.

Authors:  Zehuai Wen; Jia Wei; Huiling Xue; Yunqin Chen; David Melnick; Jesus Gonzalez; Judith Hackett; Xiaoyan Li; Zhaolong Cao
Journal:  Ther Clin Risk Manag       Date:  2018-03-13       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.